Protalix BioTherapeutics, Inc. Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions
Protalix BioTherapeutics, Inc. (PLX) reported Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-18.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions · last filed 2026-03-18
- Protalix BioTherapeutics, Inc. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2025 was $0.00.
- Protalix BioTherapeutics, Inc. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- Protalix BioTherapeutics, Inc. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2023 was $275.00K, a 48.11% decline from fiscal 2022.
- Protalix BioTherapeutics, Inc. unrecognized tax benefits, increase resulting from current period tax positions for fiscal 2022 was $530.00K.
| Period end | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions 12 month |
|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-03-18 |
| 2024-12-31 | $0.00 10-K · filed 2026-03-18 |
| 2023-12-31 | $275.00K 10-K · filed 2026-03-18 |
| 2022-12-31 | $530.00K 10-K · filed 2024-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |